News

This section keeps you up-to-date on the latest news and upcoming public appearances of Lavery professionals.

Advanced search
  1. Lavery assists Agendrix in obtaining two ISO certifications for data security and privacy

    On February 6, 2023, Agendrix, a workforce management software company, announced that it had achieved certification in two globally recognized data security and privacy standards, ISO/IEC 27001:2013 and ISO/IEC 27701:2019. This made it one of the first staff scheduling and time clock software providers in Canada to obtain these certifications. The company is proactively engaging in all matters related to the security and confidentiality of the data processed by its web and mobile applications. The ISO/IEC 27001:2013 standard is aimed at improving information security systems. For Agendrix’s customers, that means its products comply with the highest information security standards. ISO/IEC 27701:2019 provides a framework for the management and handling of personal information and sensitive data. This certification confirms that Agendrix follows best practices and complies with applicable laws. A Lavery team composed of Eric Lavallée, Dave Bouchard, Ghiles Helli and Catherine Voyer supported Agendrix in obtaining these two certifications. More specifically, our professionals assisted Agendrix in the review of their standard contract with their customers, as well as in the implementation of policies and various internal documents essential to the management of personal information and information security. Agendrix was founded in 2015, and the Sherbrooke-based company now has over 150,000 users in some 13,000 workplaces. Its personnel management software is a leader in Quebec in the field of work schedule management for small and medium-sized businesses. Agendrix’s mission is to make management more human-centred by developing software that simplifies the lives of front-line employees. Today, the company employs more than 45 people.

    Read more
  2. Lavery represents ImmunoPrecise Antibodies as it acquires BioStrand

    On March 29, 2022, ImmunoPrecise Antibodies Ltd (IPA) announced that it acquired BioStrand BV, BioKey BV, and BioClue BV (together, “BioStrand”), a group of Belgian entities pioneers in the field of bioinformatics and biotechnology. With this €20 million acquisition, IPA will be able to leverage BioStrand’s revolutionary AI-powered methodology to accelerate the development of therapeutic antibody solutions. In addition to creating synergies with its subsidiaries, IPA expects to develop new markets with this revolutionary technology and strengthen its position as a world leader in biotherapeutics. Lavery was privileged to support IPA in this cross-border transaction by providing specialized expertise in cybersecurity, intellectual property, securities and mergers and acquisitions. The Lavery team was led by Selena Lu (transactional) and included Eric Lavallée (technology and intellectual property), Serge Shahinian (intellectual property), Sébastien Vézina (securities), Catherine Méthot (transactional), Jean-Paul Timothée (securities and transactional), Siddhartha Borissov-Beausoleil (transactional), Mylène Vallières (securities) and Marie-Claude Côté (securities). ImmunoPrecise Antibodies Ltd. is a biotherapeutic, innovation-powered company that supports its business partners in their quest to discover and develop novel antibodies against a broad range of target classes and diseases.

    Read more